Analyst Ratings For NASDAQ:SCPH – Scpharmaceuticals (NASDAQ:SCPH)
Today, Jefferies Financial Group lowered its price target on NASDAQ:SCPH – Scpharmaceuticals (NASDAQ:SCPH) to per share.
Some recent analyst ratings include
- 12/12/2017-Leerink Swann initiated coverage with a Outperform ➝ Outperform rating.
- 12/12/2017-BMO Capital Markets initiated coverage with a Outperform rating.
Recent Insider Trading Activity For NASDAQ:SCPH – Scpharmaceuticals (NASDAQ:SCPH)
NASDAQ:SCPH – Scpharmaceuticals (NASDAQ:SCPH) has insider ownership of 4.80% and institutional ownership of 44.87%.
- On 11/21/2017 5Am Partners Iv, Llc, Major Shareholder, bought 654,762 with an average share price of $14.00 per share and the total transaction amounting to $9,166,668.00.
Recent Trading Activity for NASDAQ:SCPH – Scpharmaceuticals (NASDAQ:SCPH)
Shares of NASDAQ:SCPH – Scpharmaceuticals closed the previous trading session at 6.17 up +0.24 4.05% with 79509 shares trading hands.
